
Darryl J. Collins
Examiner (ID: 18520)
| Most Active Art Unit | 2872 |
| Art Unit(s) | 2872, 2873, 2507 |
| Total Applications | 2121 |
| Issued Applications | 1862 |
| Pending Applications | 100 |
| Abandoned Applications | 186 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17334461
[patent_doc_number] => 20220000792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ALBUMIN PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/477799
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477799 | Albumin pharmaceutical composition and preparation method therefor | Sep 16, 2021 | Issued |
Array
(
[id] => 17312724
[patent_doc_number] => 20210401772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITION AND METHODS FOR STIMULATING CLEARANCE OF AMYLOID-BETA PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/471619
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471619 | Composition and methods for stimulating clearance of amyloid-beta protein | Sep 9, 2021 | Issued |
Array
(
[id] => 17685795
[patent_doc_number] => 20220193087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/466495
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466495 | COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | Sep 2, 2021 | Abandoned |
Array
(
[id] => 18691108
[patent_doc_number] => 20230321316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHODS AND MATERIALS FOR EMBOLIZATION
[patent_app_type] => utility
[patent_app_number] => 18/044357
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044357
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044357 | METHODS AND MATERIALS FOR EMBOLIZATION | Sep 1, 2021 | Pending |
Array
(
[id] => 18738097
[patent_doc_number] => 20230347012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => BIORESORBABLE EMBOLIZATION PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/042573
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042573
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042573 | BIORESORBABLE EMBOLIZATION PARTICLES | Aug 30, 2021 | Abandoned |
Array
(
[id] => 18123204
[patent_doc_number] => 20230008814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => CONTINUOUS CURING RATE CHANGE TYPE GEL NAIL
[patent_app_type] => utility
[patent_app_number] => 17/405447
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405447 | CONTINUOUS CURING RATE CHANGE TYPE GEL NAIL | Aug 17, 2021 | Abandoned |
Array
(
[id] => 19150202
[patent_doc_number] => 11975092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Hair treatment compositions, methods, and kits for treating hair
[patent_app_type] => utility
[patent_app_number] => 17/403327
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11207
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403327
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403327 | Hair treatment compositions, methods, and kits for treating hair | Aug 15, 2021 | Issued |
Array
(
[id] => 17735304
[patent_doc_number] => 20220220763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => ANIMAL REPELLENT PRODUCTS, REPELLENT COMPOSITIONS AND METHODS OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/399305
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399305 | Animal repellent products, repellent compositions and methods of manufacturing the same | Aug 10, 2021 | Issued |
Array
(
[id] => 20401326
[patent_doc_number] => 12491286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Biomedical tape, preparation method therefor, and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/044681
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 0
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044681 | Biomedical tape, preparation method therefor, and application thereof | Aug 10, 2021 | Issued |
Array
(
[id] => 20607037
[patent_doc_number] => 12582616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Molecular targets for modulation of dissociative and associative states
[patent_app_type] => utility
[patent_app_number] => 18/019386
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 37
[patent_no_of_words] => 15190
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019386
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019386 | Molecular targets for modulation of dissociative and associative states | Aug 8, 2021 | Issued |
Array
(
[id] => 18699975
[patent_doc_number] => 11786461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Naloxone formulations for sublingual and/or buccal administration
[patent_app_type] => utility
[patent_app_number] => 17/395614
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7326
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395614 | Naloxone formulations for sublingual and/or buccal administration | Aug 5, 2021 | Issued |
Array
(
[id] => 17441666
[patent_doc_number] => 20220062171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS OF ADMINISTERING ANTI-EPILEPSY AGENTS AND TRANSPORT INHIBITORS TO A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 17/394588
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/394588 | Methods of administering anti-epilepsy agents and transport inhibitors to a subject | Aug 4, 2021 | Issued |
Array
(
[id] => 19089782
[patent_doc_number] => 11951201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Personal care compositions and methods for using such compositions
[patent_app_type] => utility
[patent_app_number] => 17/394148
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9688
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394148
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/394148 | Personal care compositions and methods for using such compositions | Aug 3, 2021 | Issued |
Array
(
[id] => 18869781
[patent_doc_number] => 11857561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Methods for the use of 5'-adenosine diphosphate ribose (ADPR)
[patent_app_type] => utility
[patent_app_number] => 17/392578
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 15
[patent_no_of_words] => 19539
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392578 | Methods for the use of 5'-adenosine diphosphate ribose (ADPR) | Aug 2, 2021 | Issued |
Array
(
[id] => 17241932
[patent_doc_number] => 20210361675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => SYSTEM AND METHOD FOR DIAGNOSIS AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/392264
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392264
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392264 | System and method for diagnosis and treatment | Aug 2, 2021 | Issued |
Array
(
[id] => 19195358
[patent_doc_number] => 11992577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Adhesive for surgical staple line reinforcement
[patent_app_type] => utility
[patent_app_number] => 17/443470
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 10
[patent_no_of_words] => 11772
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443470 | Adhesive for surgical staple line reinforcement | Jul 26, 2021 | Issued |
Array
(
[id] => 20663556
[patent_doc_number] => 12605305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-21
[patent_title] => Application of citrate metal salt in endodontic treatment, and formulation obtained by preparation
[patent_app_type] => utility
[patent_app_number] => 18/025339
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 27
[patent_no_of_words] => 2759
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025339 | Application of citrate metal salt in endodontic treatment, and formulation obtained by preparation | Jul 18, 2021 | Issued |
Array
(
[id] => 18626624
[patent_doc_number] => 20230285421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
[patent_app_type] => utility
[patent_app_number] => 18/005845
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005845
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005845 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | Jul 14, 2021 | Abandoned |
Array
(
[id] => 19290481
[patent_doc_number] => 12029820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Sustained release compositions of 4-aminopyridine
[patent_app_type] => utility
[patent_app_number] => 17/374285
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27233
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374285 | Sustained release compositions of 4-aminopyridine | Jul 12, 2021 | Issued |
Array
(
[id] => 17368209
[patent_doc_number] => 20220023261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/371774
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371774 | Pharmaceutical combinations for the treatment of cancer | Jul 8, 2021 | Issued |